FDA approves drugs even when experts on its advisory panels raise safety questions

Lignende værker

• FDA panel recommends approval of deferiprone
  af: Shuchman, Miriam
  Udgivet: (2011)
• FDA’s ‘Accelerated Approvals’ Are Critical But Raise Thorny Issues
  af: Miller, Henry I.
  Udgivet: (2019)
• FDA advisory panels recommend Lotronex be put back on market
  af: Charatan, Fred
  Udgivet: (2002)
• FDA Advisory Committee Approval of First Biosimilar Leaves Questions Unanswered: Sandoz’s Filgrastim Faces Naming and Court Hurdles
  af: Barlas, Stephen
  Udgivet: (2015)
• FDA Guidance and New Drug Approvals
  af: Walker, Scot
  Udgivet: (2018)